Respiratory Tract Infections; Humans; Respiratory Tract Infections/drug therapy; Anti-Bacterial Agents/therapeutic use

Baxdela; Chlamydophila pneumoniae; Clostridioides difficile; Haemophilus influenzae; Moraxella catarrhalis; Nuzyra; Streptococcus pneumoniae; Xenleta; adverse effects; amoxicillin; amoxicillin/clavulanate; antibacterials; azithromycin; bronchitis; cefadroxil; cefdinir; cefixime; cefpodoxime; ceftriaxone; cefuroxime; cephalexin; clindamycin; community-acquired pneumonia; delafloxacin; dosage; doxycycline; drug interactions; efficacy; fluoroquinolones; intranasal corticosteroids; lefamulin; levofloxacin; methicillin-resistant staphylococcus aureus; moxifloxacin; omadacycline; otitis media; penicillin; pharyngitis; pregnancy; respiratory tract infections; safety; sinusitis; trimethoprim/sulfamethoxazole